Exelixis
EXEL
#1729
Rank
S$15.17 B
Marketcap
S$56.35
Share price
2.44%
Change (1 day)
22.87%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company